Avet Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Avet Pharmaceuticals's estimated annual revenue is currently $33.2M per year.
- Avet Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Avet Pharmaceuticals has 165 Employees.
- Avet Pharmaceuticals grew their employee count by 9% last year.
Avet Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Chief Legal Officer & Chief Compliance Officer | Reveal Email/Phone |
4 | VP Human Resources | Reveal Email/Phone |
5 | Head Supply Chain | Reveal Email/Phone |
6 | VP, Assistant General Counsel | Reveal Email/Phone |
7 | VP Regulatory Affairs | Reveal Email/Phone |
8 | Head Global Operations | Reveal Email/Phone |
9 | VP Sales and Marketing | Reveal Email/Phone |
10 | VP Quality | Reveal Email/Phone |
Avet Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Avet Pharmaceuticals?
Avet Pharmaceuticals Inc. is a rapidly growing generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Avet Pharmaceuticals provides high quality generic medicines that help patients and practitioners achieve affordable healthcare solutions. Our global supply chain network is built around centers of manufacturing and scientific excellence to provide you with the highest level of quality, safety, value and service in generics. Our drug portfolio consists of numerous products across a wide range of therapeutic categories, including: cardiovascular, oncology, metabolic disease, anti-infective, infusion and pain management. We are focused on widely utilized, established products as well as niche, high barrier-to-entry products that have limited competition and long life cycles.
keywords:N/A
N/A
Total Funding
165
Number of Employees
$33.2M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator